S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Madhav Dhodapkar, MD
Rockefeller University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
- Highlands Oncology Group - Springdale
Bentonville, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Veterans Affairs Medical Center - Hines
Hines, Illinois, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Saint Luke'S Hospital - South
Overland Park, Kansas, United States
- Tammy Walker Cancer Center at Salina Regional Health Center
Salina, Kansas, United States
- Shawnee Mission Medical Center
Shawnee Mission, Kansas, United States
- Cotton-O'Neil Cancer Center
Topeka, Kansas, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Lahey Clinic Medical Center - Burlington
Burlington, Massachusetts, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Clemens Regional Medical Center
Mount Clemens, Michigan, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Heartland Hematology Oncology Associates, Incorporated
Kansas City, Missouri, United States
- North Kansas City Hospital
Kansas City, Missouri, United States
- Parvin Radiation Oncology
Kansas City, Missouri, United States
- Research Medical Center
Kansas City, Missouri, United States
- Saint Luke'S Cancer Institute at Saint Luke'S Hospital
Kansas City, Missouri, United States
- St. Joseph Medical Center
Kansas City, Missouri, United States
- Saint Luke'S East - Lee'S Summit
Lee's Summit, Missouri, United States
- Liberty Hospital
Liberty, Missouri, United States
- Heartland Regional Medical Center
Saint Joseph, Missouri, United States
- Saint Joseph Oncology, Incorporated
Saint Joseph, Missouri, United States
- Saint Louis University Cancer Center
St Louis, Missouri, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana, United States
- Northern Rockies Radiation Oncology Center
Billings, Montana, United States
- St. Vincent Healthcare Cancer Care Services
Billings, Montana, United States
- Bozeman Deaconess Cancer Center
Bozeman, Montana, United States
- St. James Healthcare Cancer Care
Butte, Montana, United States
- Big Sky Oncology
Great Falls, Montana, United States
- Great Falls Clinic - Main Facility
Great Falls, Montana, United States
- Sletten Cancer Institute at Benefis Healthcare
Great Falls, Montana, United States
- Northern Montana Hospital
Havre, Montana, United States
- St. Peter'S Hospital
Helena, Montana, United States
- Glacier Oncology, Pllc
Kalispell, Montana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2002
- Primary completion
- 30 Apr 2016
- Completion
- —
- Last update posted
- 7 Oct 2016
- Registered enrollment
- 375
- Registry id
- NCT00900263
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.